Elevated Red Cell Distribution Width as a Potential Marker of Acute Mountain Sickness in Chinese Young Men Upon Rapidly Ascending to 3,650 m.

Authors

Xugang Tang, Luxun Tang, Shuang Li, Xiuchuan Li, Xiaoyu Li, Qiang Wang, Yongjian Yang

Published in

International journal of general medicine. Volume 19. Pages 620783. Epub Jul 10, 2026.

Abstract

Elevated red cell distribution width (RDW) has been implicated in chronic mountain sickness; however, its relationship with acute mountain sickness (AMS) remains uncertain. We aimed to evaluate the association between elevated RDW and AMS among Chinese young men undergoing high-altitude air ascent.
157 participants (median age, 22 years) were enrolled and passively ascended primarily by air from 500 m to 3,650 m, spending approximately 3.5 hours. Participants were classified as AMS+ and AMS- based on their Lake Louise AMS score (LLS) after 24 hours at 3,650 m. Measurements included heart rate (HR), blood pressure, pulse oximeter saturation (SpO₂), and complete blood count (CBC). Statistical analyses included correlation analysis, logistic regression, and receiver operating characteristic (ROC) curve analysis.
The prevalence of AMS at 3,650 m was 45%. AMS+ participants had higher HR and RDW and lower SpO₂ than AMS- participants. LLS was positively correlated with age, BMI, HR, and RDW, and negatively correlated with SpO₂. Adjusted logistic regression revealed independent risk factors for AMS, including lower SpO₂ (odds ratio [OR] = 0.809, P < 0.01), higher RDW coefficient of variation (RDW-CV) (OR = 2.790, P < 0.01), and a higher neutrophil-to-monocyte ratio (OR = 1.114, P < 0.05). ROC curve analysis demonstrated that elevated RDW-CV is a significant diagnostic indicator for AMS, with an optimal cutoff of 13.7, yielding a sensitivity of 94.37%, specificity of 45.35%, and an area under the curve (AUC) of 0.703.
The findings suggest that elevated RDW-CV is linked to an increased risk of AMS among Chinese young men primarily undergoing air ascent to 3,650 m.

PMID:
42454354
Bibliographic data and abstract were imported from PubMed on 15 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.